Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.

The Journal of infectious diseases - 1 Sept 2013

Fournillier Anne, Frelin Lars, Jacquier Emilie, Ahlén Gustaf, Brass Anette, Gerossier Estelle, Holmström Fredrik, Broderick Kate E, Sardesai Niranjan Y, Bonnefoy Jean-Yves, Inchauspé Geneviève, Sällberg Matti

Abstract excerpt

BACKGROUND: We explored the concept of heterologous prime/boost vaccination using 2 therapeutic vaccines currently in clinical development aimed at treating chronically infected hepatitis C virus (HCV) patients: prime with a DNA-based vaccine expressing HCV genotype 1a NS3/4A proteins (ChronVac-C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Formation
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD8-Positive T-Lymphocytes

Share to Immunization, Secondary

Share to Interleukin-2

Share to Vaccination

Share to Vaccines, DNA

Share to Viral Hepatitis Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 23776192
DOI: 10.1093/infdis/jit267
PMCID: PMC3749006

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23776192-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.PMID 23776192Read ↗

Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunitySemantic proximity Read ↗

Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.Semantic proximity Read ↗

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.Semantic proximity Read ↗

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.Semantic proximity Read ↗

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.Semantic proximity Read ↗

A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice.Semantic proximity Read ↗

Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV Related Liver CancerSemantic proximity Read ↗

Removal of the C6 vaccinia virus interferon-β inhibitor in the hepatitis C vaccine candidate MVA-HCV elicited in mice high immunogenicity in spite of reduced host gene expressionSemantic proximity Read ↗

Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.Semantic proximity Read ↗

Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.